Tue, October 11, 2016
Mon, October 10, 2016
Fri, October 7, 2016
Thu, October 6, 2016
Wed, October 5, 2016
Tue, October 4, 2016
Mon, October 3, 2016
Fri, September 30, 2016

Paul Matteis Downgraded (ALNY) to Hold and Decreased Target to $40 on, Oct 6th, 2016


//stocks-investing.news-articles.net/content/201 .. -and-decreased-target-to-40-on-oct-6th-2016.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Paul Matteis of Leerink Swann, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold and Decreased Target from $107 to $40 on, Oct 6th, 2016.

Paul has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $83 on, Friday, August 5th, 2016

Publication Contributing Sources